Monte Rosa Therapeutics, Inc. GLUE
10.41 USD -0.22 (-2.07%)
At closeNov 4, 2026, 7:38 AM EST
10.41 0.00 0.00%
Pre-market · Nov 4, 7:38 AM ET
10.37 Day range 10.90
9.68 52-week range 25.77
- YTD
- -33.61%
- 1 year
- -13.25%
Held by funds
100 US ETFs and mutual funds hold GLUE · largest positions
Ownership
Held by insiders 0.56%
Held by institutions 116.10%
Float held by institutions 116.75%
Institutions 263
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) Associates Inc | 10.39% | 8,861,171 | 105.71M | Jun 29, 2026 |
| NEA Management Company, LLC | 9.02% | 7,692,298 | 91.77M | Jun 29, 2026 |
| Blackrock Inc. | 8.02% | 6,843,087 | 81.64M | Jun 29, 2026 |
| TCG Crossover Management, LLC | 5.42% | 4,622,151 | 55.14M | Jun 29, 2026 |
| Vestal Point Capital, LP | 5.39% | 4,600,000 | 54.88M | Jun 29, 2026 |
| BVF Inc. | 5.23% | 4,460,886 | 53.22M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.99% | 2,550,827 | 30.43M | Jun 29, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 2.62% | 2,232,091 | 26.63M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.62% | 2,231,487 | 26.62M | Aug 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.23% | 1,899,251 | 22.66M | Aug 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 2.14% | 1,823,210 | 21.75M | Jun 29, 2026 |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 1.61% | 1,375,639 | 16.41M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOWEN MATTHEW | Officer | Stock Award(Grant) | Apr 5, 2026 | 25,904 |
| CHAMPOUX JENNIFER | Chief Operating Officer | Sale | Jul 14, 2026 | 62,371 |
| DUNN EDMUND | Officer | Sale | Mar 3, 2026 | 22,554 |
| JANKU FILIP | Officer | Sale | Jun 29, 2026 | 60,612 |
| LEO CHANDRA P. MD | Director | Purchase | Mar 23, 2025 | 10,000 |
| MANNING ANTHONY M | Director | Sale | Jun 28, 2026 | 0 |